CLINICAL_TRIALS
trial_result
· 2011-10-04
Clinical Trial Update: A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy
Summary
This completed study evaluated the use of FDG-PET, breast MRI, and breast ultrasonography to monitor tumor response in locally advanced breast cancer patients u…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Locally Advanced Breast Cancer | Status: COMPLETED